AXSM
Axsome Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$207.78
−3.03%Forward multiples
Based on analyst estimates
- P/E forward
- 1239.69x
- P/E 2026E
- —
- P/E 2027E
- 44.90x
- P/E 2028E
- 16.65x
- P/S forward
- 9.07x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 130.65x
- Price / sales
- 14.02x
- Price / cash flow
- -152.73x
Enterprise value
- Enterprise value
- $10.8B
- EV / sales
- 13.89x
- EV / EBITDA
- -59.97x
- EV / EBIT
- -57.19x
- Market cap
- $10.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026